Second Opinion: Promising Trends in Cancer Treatment, Part 1

Podcast

Is the cancer establishment inherently biased against low-tech natural therapies? Dr. Hoffman interviews Ralph Moss, Ph.D. and filmmaker Eric Merola on their new movie, Second Opinion: Did Memorial Sloane Kettering Cancer Center deep-six promising data on Laetrile in the 1970s? Was their motive to suppress unconventional cancer treatments? Why is it important to re-litigate this case four decades later? Dr. Moss weighs in on promising trends in cancer treatment, both mainstream and alternative: ketogenic diet, targeted immunotherapy, hyperthermia, Avemar, Essiac tea, mushrooms, proteolytic enzymes, IV vitamin C.

Share:
Play
Subscribe to the Intelligent Medicine Podcast for Free from your Favorite Podcast Provider






Facebook Twitter YouTube RSS Stitcher Apple Podcasts

  • Estrogen dominance syndrome

    Though we think of declining estrogen as the hallmark of menopause, it's actually common for…

  • Ulcers
    Ulcers

    Up to 12 percent of Americans have ulcers at some point in life. Peptic ulcers…

  • Gallbladder disease

    Gallbladder disease is a modern illness. An estimated 20 million Americans have gallbladder disease. The…

featured product


NTFactor® with D3/K2 is a tasty, chewable wafer that helps restore your energy,* reduces fatigue*, and gives the additional benefit of vitamin D3 and K2 supplementation.

Recent studies have suggested that up to 50% of adults and children worldwide are vitamin D deficient. Vitamin D has multiple roles in the body, including:

  • Maintaining the health of bones and teeth*
  • Supporting the health of the brain and nervous system*
  • Supporting the health of the immune system*
For a limited time, you can get 20% off NTFactor® with D3/K2 at NTFactor.com with code: D3SUPPORT

More...

TWITTER